Oppenheimer
Upgrade grade
A
Downgrade grade
B
Oppenheimer & Co. was founded in 1881 as a private banking partnership and has evolved into a full-service investment bank headquartered in New York with significant research and trading operations. The firm employs thousands of professionals across its various divisions and maintains a substantial presence in equity research, with approximately 6,160 analyst ratings calls on US equities demonstrating the breadth of their coverage universe. Oppenheimer is particularly well-known for its deep expertise in technology, healthcare, financial services, and industrials, where their analysts have built strong track records of identifying inflection points and emerging growth opportunities. The firm has cultivated a distinctive culture of independent research, with a reputation for allowing their analysts to maintain contrarian positions when warranted by fundamentals, rather than herding toward consensus views that characterize much of the sell-side research industry.
Upgrades
428
78.97% win rate
· avg +3.19% D1
Downgrades
495
75.56% win rate
· avg -5.71% D1
Avg Gap — Upgrades
+2.67%
open vs prev close
Avg Gap — Downgrades
-5.53%
open vs prev close
Performance by Sector
| Sector | ↑ Win% | ↑ D1 | ↓ Win% | ↓ D1 |
|---|---|---|---|---|
| Technology | 78.64% (103) | +4.12% | 75.89% (112) | -6.15% |
| Healthcare | 84.81% (79) | +4.46% | 76.54% (81) | -11.74% |
| Consumer Cyclical | 81.25% (64) | +2.29% | 71.43% (84) | -3.03% |
| Industrials | 76.92% (52) | +2.40% | 86.15% (65) | -4.10% |
| Financial Services | 78.43% (51) | +2.16% | 63.16% (57) | -1.45% |
| Communication Services | 77.42% (31) | +2.78% | 83.87% (31) | -8.83% |
| Consumer Defensive | 56.25% (16) | +0.83% | 90.91% (22) | -5.70% |
| Energy | 63.64% (11) | +3.66% | 61.90% (21) | -4.36% |
| Real Estate | 90.91% (11) | +2.85% | 80.00% (15) | -1.76% |
Win Rate by Year
| Year | ↑ Win% | ↑ Calls | ↓ Win% | ↓ Calls |
|---|---|---|---|---|
| 2026 | 78.3% | 23 | 78.3% | 23 |
| 2025 | 84.4% | 32 | 64.0% | 25 |
| 2024 | 81.3% | 32 | 88.6% | 35 |
| 2023 | 72.7% | 22 | 78.9% | 57 |
| 2022 | 78.4% | 37 | 72.1% | 43 |
| 2021 | 73.7% | 38 | 83.8% | 37 |
| 2020 | 78.8% | 52 | 63.2% | 38 |
| 2019 | 82.6% | 23 | 74.4% | 43 |
| 2018 | 68.0% | 25 | 79.2% | 24 |
| 2017 | 81.0% | 21 | 66.7% | 21 |
Recent Calls
| Date | Ticker | Company | Sector | Action | Grade Change | PT | Gap | D1 |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | MS | Morgan Stanley | Financial Services | Downgrade | Perform → Underperform | — | -0.7% | -1.3% |
| Jun 30, 2026 | GS | The Goldman Sachs Group, Inc. | Financial Services | Downgrade | Perform → Underperform | — | -0.1% | -0.9% |
| Jun 30, 2026 | C | Citigroup Inc. | Financial Services | Downgrade | Outperform → Perform | — | -1.0% | -1.8% |
| Jun 30, 2026 | BAC | Bank of America Corporation | Financial Services | Downgrade | Outperform → Perform | — | -0.7% | -1.6% |
| Jun 29, 2026 | VSAT | Viasat, Inc. | Technology | Initiates | Outperform | $140 | +8.8% | +23.8% |
| Jun 29, 2026 | NRIX | Nurix Therapeutics, Inc. | Healthcare | Reiterates | Outperform | $28 | +1.1% | +4.1% |
| Jun 29, 2026 | SEZL | Sezzle Inc. | Financial Services | Downgrade | Outperform → Perform | — | -1.1% | +0.1% |
| Jun 26, 2026 | EPRX | Eupraxia Pharmaceuticals Inc. | Healthcare | Initiates | Outperform | $17 | +0.3% | +3.0% |
| Jun 22, 2026 | BBOT | BridgeBio Oncology Therapeutics Inc. | Healthcare | Reiterates | Outperform | $22 | +2.2% | +4.1% |
| Jun 22, 2026 | ONTO | Onto Innovation Inc. | Technology | Reiterates | Outperform | $450 | +3.8% | +4.2% |
| Jun 18, 2026 | SPCX | Space Exploration Technologies Corp. | Industrials | Reiterates | Outperform | $250 | -1.8% | -3.6% |
| Jun 17, 2026 | BV | BrightView Holdings, Inc. | Industrials | Initiates | Outperform | $17 | +0.0% | -1.2% |
| Jun 11, 2026 | SPCX | Space Exploration Technologies Corp. | Industrials | Initiates | Outperform | — | — | — |
| Jun 10, 2026 | IKT | Inhibikase Therapeutics, Inc. | Healthcare | Initiates | Outperform | $5 | +2.4% | -0.6% |
| Jun 9, 2026 | DTIL | Precision BioSciences, Inc. | Healthcare | Initiates | Outperform | $20 | +3.0% | +1.3% |
| Jun 9, 2026 | LYTS | LSI Industries Inc. | Technology | Initiates | Outperform | $30 | +2.1% | +4.6% |
| Jun 9, 2026 | INGR | Ingredion Incorporated | Consumer Defensive | Downgrade | Outperform → Perform | — | -2.0% | +2.0% |
| Jun 5, 2026 | RBRK | Rubrik, Inc. | Technology | Reiterates | Outperform | $90 | +0.0% | -4.7% |
| Jun 5, 2026 | NAVN | Navan, Inc. | Technology | Reiterates | Outperform | $28 | +1.1% | -4.8% |
| Jun 3, 2026 | T | AT&T Inc. | Communication Services | Downgrade | Outperform → Perform | — | -1.8% | -4.4% |
| Jun 2, 2026 | ODTX | — | — | Initiates | Outperform | $40 | +0.6% | -0.2% |
| May 28, 2026 | VMI | Valmont Industries, Inc. | Industrials | Reiterates | Outperform | $600 | +0.5% | +0.5% |
| May 28, 2026 | KNF | Knife River Corporation | Basic Materials | Reiterates | Outperform | $95 | -1.2% | +0.6% |
| May 28, 2026 | ECG | Everus Construction Group, Inc. | Industrials | Reiterates | Outperform | $185 | -0.2% | +0.0% |
| May 28, 2026 | ACA | Arcosa, Inc. | Industrials | Reiterates | Outperform | $150 | +1.7% | +0.3% |